← Leaderboards
Fabien Maldonado
Vanderbilt University Medical Center
$4,614,341
Attributed
$7,312,421
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,312,421 · 3
By mechanism
R01$5,396,160 · 2
U01$1,916,261 · 1
Top collaborators
- Bennett A. Landman6 shared
- Marc Elliott Lenburg3 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Stephen Deppen$3,055,842
- Douglas Ruderfer$8,775,014
- Colin George Walsh$3,971,490
- Deepak Gupta$5,627,629
- Jeffrey C Rathmell$23,426,807
Others in their field
Other Emerging Leaders on “Lung Cancer Screening”
- Leonard Freedman · Leidos Biomedical Research, Inc.$50,919,602
- Lynn Briscoe · Leidos Biomedical Research, Inc.$26,195,254
- Anna Fernandez · Booz Allen Hamilton$7,205,078
- Summer S Han · Stanford University$6,249,332
- Lisa Carter-Bawa · Sloan-Kettering Inst Can Research$5,953,672
- Leonard Freedmand · Leidos Biomedical Research, Inc.$5,019,549
Research focus
Lung Cancer ScreeningImagePredictive ModelingCohortBiological MarkersMalignant Neoplasm Of LungHealth Care CostsMolecular MarkerOperative Surgical ProceduresAcademic Medical CentersMorbidity - Disease RateCessation Of LifeValidationLungCancer DetectionMortalityRadiology SpecialtyClinical PredictorsChest Computed TomographyLung NoduleMeasurementEnrollmentFundingDiagnosis
Grant awards (11)
Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures$649,247
R01 · FY2025 · CA · contact PI
Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma$641,388
R01 · FY2025 · CA
Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures$624,698
R01 · FY2024 · CA · contact PI
Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma$607,822
R01 · FY2024 · CA
Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures$175,000
R01 · FY2024 · CA · contact PI
Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma$704,857
R01 · FY2023 · CA
Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures$651,171
R01 · FY2023 · CA · contact PI
Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures$659,921
R01 · FY2022 · CA · contact PI
Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures$682,056
R01 · FY2021 · CA · contact PI
Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma$681,562
U01 · FY2020 · CA · contact PI
Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma$1,234,699
U01 · FY2019 · CA · contact PI